These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 3544766)

  • 1. Proapolipoprotein-converting enzymes and high-density lipoprotein early events in biogenesis.
    Scanu AM
    Am Heart J; 1987 Feb; 113(2 Pt 2):527-32. PubMed ID: 3544766
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo conversion of recombinant human proapolipoprotein AI (rh-Met-proapo AI) to apolipoprotein AI in rabbits.
    Saku K; Liu R; Ohkubo K; Bai H; Hirata K; Yamamoto K; Morimoto Y; Yamada K; Arakawa K
    Biochim Biophys Acta; 1993 Apr; 1167(3):257-63. PubMed ID: 8481386
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human proapolipoprotein A-II is cleaved following secretion from Hep G2 cells by a thiol protease.
    Gordon JI; Sims HF; Edelstein C; Scanu AM; Strauss AW
    J Biol Chem; 1984 Dec; 259(24):15556-63. PubMed ID: 6096378
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Decreased proapolipoprotein A-I processing in liver disease: evidence for hepatic participation in proapolipoprotein A-I conversion.
    Isobe H; Sakai H; Satoh M; Sakamoto S; Koga S; Nawata H
    Clin Chim Acta; 1990 Aug; 189(3):303-11. PubMed ID: 2121392
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Extracellular processing of proapolipoprotein A-II in Hep G2 cell cultures is mediated by a 54-kDa protease immunologically related to cathepsin B.
    Gordon JI; Sims HF; Edelstein C; Scanu AM; Strauss AW
    J Biol Chem; 1985 Nov; 260(27):14824-31. PubMed ID: 2414299
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increase of plasma proapolipoprotein A-I in patients with liver cirrhosis and its relationship to circulating high-density lipoproteins 2 and 3.
    Suehiro T; Yamamoto M; Yoshida K; Ohno F
    Clin Chem; 1993 Jan; 39(1):60-5. PubMed ID: 8419059
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro reverse cholesterol transport from THP-1-derived macrophage-like cells with synthetic HDL particles consisting of proapolipoprotein A1 or apolipoprotein A1 and phosphatidylcholine.
    Westman J; Roobol C; Carlson LA; Wülfert E
    Scand J Clin Lab Invest; 1995 Feb; 55(1):23-33. PubMed ID: 7624733
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Isoforms of apolipoprotein A-II in human plasma and thoracic duct lymph. Identification of proapolipoprotein A-II and sialic acid-containing isoforms.
    Lackner KJ; Edge SB; Gregg RE; Hoeg JM; Brewer HB
    J Biol Chem; 1985 Jan; 260(2):703-6. PubMed ID: 2981844
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Apolipoprotein A-I-containing lipoproteins in human umbilical cord blood. Relation to proapolipoprotein A-I and lecithin:cholesterol acyltransferase.
    Barkia A; Thiemann E; Czekelius P; Wiegel A; Leroy A; Fruchart JC; Steinmetz A
    Biol Neonate; 1991; 59(6):352-7. PubMed ID: 1908326
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased proportion of proapolipoprotein A-I in HDL from patients with liver cirrhosis and hepatitis.
    Matsuura T; Koga S; Ibayashi H
    Gastroenterol Jpn; 1988 Aug; 23(4):394-400. PubMed ID: 2846400
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Apolipoproteins of human plasma high density lipoproteins. Biology, biochemistry and clinical significance.
    Scanu AM; Edelstein C; Gordon JI
    Clin Physiol Biochem; 1984; 2(2-3):111-22. PubMed ID: 6435927
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lipoprotein affinity of human apolipoprotein A-IV during cholesterol esterification.
    Weinberg RB; Spector MS
    Biochem Biophys Res Commun; 1986 Mar; 135(3):756-63. PubMed ID: 3964275
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modulation of lipoprotein production in Hep G2 cells by fenofibrate and clofibrate.
    Hahn SE; Goldberg DM
    Biochem Pharmacol; 1992 Feb; 43(3):625-33. PubMed ID: 1311585
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Limited proteolysis of high density lipoprotein abolishes its interaction with cell-surface binding sites that promote cholesterol efflux.
    Mendez AJ; Oram JF
    Biochim Biophys Acta; 1997 Jun; 1346(3):285-99. PubMed ID: 9219913
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of serum amyloid A on cholesterol esterification in human plasma.
    Steinmetz A; Hocke G; Saïle R; Puchois P; Fruchart JC
    Biochim Biophys Acta; 1989 Nov; 1006(2):173-8. PubMed ID: 2512983
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structural and functional properties of full-length and truncated human proapolipoprotein AI expressed in escherichia coli.
    Pyle LE; Sawyer WH; Fujiwara Y; Mitchell A; Fidge NH
    Biochemistry; 1996 Sep; 35(37):12046-52. PubMed ID: 8810909
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A serum proteinase converts proapolipoprotein AI secreted by rat hepatocytes to the mature apolipoprotein.
    Stoffel W; Knyrim K; Bode C
    Hoppe Seylers Z Physiol Chem; 1983 Nov; 364(11):1631-40. PubMed ID: 6420309
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tangier disease: defective recombination of a specific Tangier apolipoprotein A-I isoform (pro-apo A-i) with high density lipoproteins.
    Schmitz G; Assmann G; Rall SC; Mahley RW
    Proc Natl Acad Sci U S A; 1983 Oct; 80(19):6081-5. PubMed ID: 6412234
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Receptors and molecular heterogeneity of lipoprotein particles containing apolipoprotein A-I].
    Broutin H; Puchois P; Ailhaud G; Barbaras R; Torpier G; Fruchart JC
    Ann Biol Clin (Paris); 1988; 46(1):16-23. PubMed ID: 2839056
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pre-beta high density lipoprotein. Unique disposition of apolipoprotein A-I increases susceptibility to proteolysis.
    Kunitake ST; Chen GC; Kung SF; Schilling JW; Hardman DA; Kane JP
    Arteriosclerosis; 1990; 10(1):25-30. PubMed ID: 2136993
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.